On October 10, 2018, Cardialen, Inc. closed the transaction. The company has received total of $17,000,000 in its series B round of funding led by new investor RiverVest Venture Partners, LLC. The company has received $927,953 in the final tranche. The transaction also included participation from new investors Qiming Weichuang Venture Capital Management (Shanghai) Company Limited, returning investor Cultivation Capital, and HBM Healthcare Investments AG (SWX:HBMN), a fund managed by nebag ag (SWX:NBEN) and HBM Partners Ltd. As part of the round, Jay Schmelter of RiverVest Venture Partners, LLC, Christopher Shen of Qiming Weichuang Venture Capital Management (Shanghai) Company Limited and Thomas Thaler, of nebag ag (SWX:NBEN) and HBM Partners Ltd. joined the company's board of directors.